Zacks Investment Management raised its position in shares of Phibro Animal Health Co. (NASDAQ:PAHC – Free Report) by 329.5% in the fourth quarter, HoldingsChannel.com reports. The firm owned 52,222 shares of the company’s stock after buying an additional 40,064 shares during the period. Zacks Investment Management’s holdings in Phibro Animal Health were worth $1,097,000 at the end of the most recent reporting period.
Several other hedge funds also recently modified their holdings of the company. Geode Capital Management LLC raised its position in Phibro Animal Health by 5.7% in the third quarter. Geode Capital Management LLC now owns 507,469 shares of the company’s stock worth $11,430,000 after acquiring an additional 27,201 shares in the last quarter. Barclays PLC lifted its stake in Phibro Animal Health by 25.7% during the third quarter. Barclays PLC now owns 143,337 shares of the company’s stock valued at $3,228,000 after purchasing an additional 29,271 shares during the last quarter. Smith Group Asset Management LLC bought a new stake in Phibro Animal Health during the fourth quarter worth approximately $541,000. Inspire Investing LLC acquired a new position in Phibro Animal Health in the fourth quarter worth approximately $791,000. Finally, Alliancebernstein L.P. increased its holdings in shares of Phibro Animal Health by 357.1% in the fourth quarter. Alliancebernstein L.P. now owns 130,000 shares of the company’s stock valued at $2,730,000 after buying an additional 101,560 shares in the last quarter. 99.34% of the stock is currently owned by institutional investors and hedge funds.
Analysts Set New Price Targets
Several equities research analysts have recently weighed in on PAHC shares. Morgan Stanley set a $20.00 price objective on Phibro Animal Health in a research note on Tuesday. Barclays lifted their price target on Phibro Animal Health from $20.00 to $22.00 and gave the stock an “underweight” rating in a research note on Monday, February 10th. Finally, StockNews.com lowered shares of Phibro Animal Health from a “buy” rating to a “hold” rating in a research note on Tuesday, March 25th. Two research analysts have rated the stock with a sell rating and three have issued a hold rating to the company. According to MarketBeat, Phibro Animal Health currently has an average rating of “Hold” and a consensus price target of $19.75.
Phibro Animal Health Price Performance
PAHC opened at $17.29 on Friday. Phibro Animal Health Co. has a 12-month low of $12.30 and a 12-month high of $26.55. The company has a quick ratio of 1.37, a current ratio of 3.20 and a debt-to-equity ratio of 2.99. The firm has a market capitalization of $700.30 million, a P/E ratio of 36.02, a PEG ratio of 0.45 and a beta of 0.63. The stock has a fifty day moving average of $21.46 and a 200-day moving average of $22.28.
Phibro Animal Health (NASDAQ:PAHC – Get Free Report) last announced its quarterly earnings data on Wednesday, February 5th. The company reported $0.54 EPS for the quarter, topping analysts’ consensus estimates of $0.40 by $0.14. Phibro Animal Health had a return on equity of 25.35% and a net margin of 1.75%. Equities analysts forecast that Phibro Animal Health Co. will post 1.95 EPS for the current fiscal year.
Phibro Animal Health Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Wednesday, March 5th were paid a $0.12 dividend. The ex-dividend date was Wednesday, March 5th. This represents a $0.48 annualized dividend and a yield of 2.78%. Phibro Animal Health’s dividend payout ratio is presently 100.00%.
Phibro Animal Health Company Profile
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.
See Also
- Five stocks we like better than Phibro Animal Health
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Mid-Cap to Mega-Cap Stocks Have Announced Significant Buybacks
- CD Calculator: Certificate of Deposit Calculator
- These 3 Stocks Have Huge Last 12 Months Shareholder Yields
- Investing In Automotive Stocks
- Prominent Hedge Fund Acquires Huge Stake in HPE: Is It a Buy Now?
Want to see what other hedge funds are holding PAHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Phibro Animal Health Co. (NASDAQ:PAHC – Free Report).
Receive News & Ratings for Phibro Animal Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health and related companies with MarketBeat.com's FREE daily email newsletter.